Skip to content

Public FDA record

Z-0680-2025: Turbo Elite Laser Atherectomy Catheter Model Number / UDI-DI code / Product Description 414-151 / 9899300

Recall record Z-0680-2025 for Spectranetics Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0680-2025
Company in FDA record
Spectranetics Corporation
FDA classification date
Dec 16, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to complaints received for the marker band detaching from the distal tip of the catheter and remaining in the patient as laser catheter was retracted.

Source facts

Action
On 11/25/2024, the firm sent an "URGENT MEDICAL DEVICE CORRECTION" Letter via USPS certified mail to customer informing them that Philips has become aware of a potential safety issue with a limited number of Turbo-Elite Laser Atherectomy Catheters where the marker band has the potential to become detached from the device. Detached marker band are visible under fluoroscopy and should remain on the guidewire. Since a detached marker band requires additional intervention to retrieve, temporary or medically reversible adverse health consequences are possible. The potential clinical harms of a detached marker band are embolization, dissection, or perforation, which are harms listed in the Adverse Event Procedural Complications section of the Instructions for Use. Actions to be taken by Customer: Philips recommends the continued use of the Turbo-Elite Laser Atherectomy Catheter and to follow the Instructions for Use, including using fluoroscopy to ensure the marker band is not left behind after retracting the device. As a precaution, if a marker band detaches and remains on the wire in the patient, then additional intervention to retrieve the marker band is required. There are multiple possible endovascular interventions to retrieve a detached marker band including snaring, balloon catheter inflation, and using a filter wire to capture the marker band. If these techniques are unsuccessful, then stenting can be used to secure the marker band in place to avoid distal embolization. Ensure you report all occurrences of this issue to Philips via a complaint. For questions or assistance-contact local Philips representative or Philips Image Guided Therapy Devices Customer Service at 1-800-231-0978, option 2.
Initiated
2024-11-25
Root cause
Device Design
Distribution
U.S.: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, ILIN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD TN, TX, UT, VA, WA, WI, and WV. O.U.S.: Australia, Belgium, Brazil, China, Croatia, Cyprus, Czech Republic, Denmark, France, Germany, Italy, Japan, Kuwait, Netherlands, Poland, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom.
Recall number
Z-0680-2025
Recall status
Open, Classified
CDRH record ID
211283
FDA classified
2024-12-16
Recall event number
95815

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗